These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18477489)

  • 41. Birth intervals and injectable contraception in sub-Saharan Africa.
    Ngianga-Bakwin K; Stones RW
    Contraception; 2005 May; 71(5):353-6. PubMed ID: 15854636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women.
    Lizarelli PM; Martins WP; Vieira CS; Soares GM; Franceschini SA; Ferriani RA; Patta MC
    Contraception; 2009 Jan; 79(1):35-40. PubMed ID: 19041439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current concepts regarding use of DMPA.
    Kaunitz AM
    J Reprod Med; 2002 Sep; 47(9 Suppl):785-9. PubMed ID: 12380407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Depo Now: preventing unintended pregnancies among adolescents and young adults.
    Rickert VI; Tiezzi L; Lipshutz J; León J; Vaughan RD; Westhoff C
    J Adolesc Health; 2007 Jan; 40(1):22-8. PubMed ID: 17185202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. When can a woman have repeat progestogen-only injectables--depot medroxyprogesterone acetate or norethisterone enantate?
    Paulen ME; Curtis KM
    Contraception; 2009 Oct; 80(4):391-408. PubMed ID: 19751863
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of a provider job aid intervention on injectable contraceptive continuation in South Africa.
    Baumgartner JN; Morroni C; Mlobeli RD; Otterness C; Buga G; Chen M
    Stud Fam Plann; 2012 Dec; 43(4):305-14. PubMed ID: 23239249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Body weight and bleeding pattern changes in women using DMPA-SC.
    Chaudhri R; Rizvi F; Afzal M
    J Coll Physicians Surg Pak; 2009 Oct; 19(10):618-21. PubMed ID: 19811711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contraceptive efficacy and safety of DMPA-SC.
    Jain J; Jakimiuk AJ; Bode FR; Ross D; Kaunitz AM
    Contraception; 2004 Oct; 70(4):269-75. PubMed ID: 15451329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Performance of contraceptive patch compared with oral contraceptive pill in a high-risk population.
    Bakhru A; Stanwood N
    Obstet Gynecol; 2006 Aug; 108(2):378-86. PubMed ID: 16880309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Helping women choose appropriate hormonal contraception: update on risks, benefits, and indications.
    Spencer AL; Bonnema R; McNamara MC
    Am J Med; 2009 Jun; 122(6):497-506. PubMed ID: 19486709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized assignment to copper IUD or depot-medroxyprogesterone acetate: feasibility of enrollment, continuation and disease ascertainment.
    Feldblum PJ; Caraway J; Bahamondes L; El-Shafei M; Quan Ha D; Morales E; Wevill S; Condon S
    Contraception; 2005 Sep; 72(3):187-91. PubMed ID: 16102553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contraceptive use and pregnancy outcome in three generations of Swedish female teenagers from the same urban population.
    Lindh I; Blohm F; Andersson-Ellström A; Milsom I
    Contraception; 2009 Aug; 80(2):163-9. PubMed ID: 19631792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluating the feasibility and acceptability of self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA) in Senegal: a prospective cohort study.
    Cover J; Ba M; Lim J; Drake JK; Daff BM
    Contraception; 2017 Sep; 96(3):203-210. PubMed ID: 28673645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of sexually transmitted infections among HIV-infected women using depot medroxyprogesterone acetate contraception.
    Overton ET; Shacham E; Singhatiraj E; Nurutdinova D
    Contraception; 2008 Aug; 78(2):125-30. PubMed ID: 18672113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The discordance between planned use and actual receipt of immediate postpartum depot medroxyprogesterone among low-income women.
    Brownell EA; Lussier MM; Dozier AM; Howard CR; Fisher SG; Duckett JW; Lawrence RA; Fernandez ID
    Breastfeed Med; 2014; 9(6):290-3. PubMed ID: 24893264
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hormonal contraception and HIV prevalence in four African countries.
    Leclerc PM; Dubois-Colas N; Garenne M
    Contraception; 2008 May; 77(5):371-6. PubMed ID: 18402855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Usefulness of FSH measurements for determining menopause in long-term users of depot medroxyprogesterone acetate over 40 years of age.
    Juliato CT; Fernandes A; Marchi NM; Castro S; Olivotti B; Bahamondes L
    Contraception; 2007 Oct; 76(4):282-6. PubMed ID: 17900438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Painless Depo-medroxyprogesterone acetate (DMPA) injections using the 'pinch technique'.
    Fletcher H
    J Obstet Gynaecol; 2004 Aug; 24(5):562-3. PubMed ID: 15369941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Operational assessments of Sayana® Press provision in Senegal and Uganda.
    Cover J; Blanton E; Ndiaye D; Walugembe F; Lamontagne DS
    Contraception; 2014 May; 89(5):374-8. PubMed ID: 24565737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Injectable contraceptive, the promising alternative.
    Koetsawang S
    J Med Assoc Thai; 1975 Dec; 58(12):606-13. PubMed ID: 1206260
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.